Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
PubMed laboratory research record [PMID: 40991735] PubMed record related to this compound for laboratory literature review
In 2021, semaglutide was approved by FDA for weight loss and quickly achieved commercial success
Some peptides are not FDA-approved and are considered investigational
Start with your source
A clinical trial that involved GHK-Cu in addition to standard wound care also reported an apparently reduced risk of infection compared to standard processes alone
IGF-1R Binding and Downstream Signalling IGF-1 LR3 remains a full agonist of the IGF-1 receptor, with very low affinity for IGFBPs making it more potent than unmodified IGF-1 in cell culture and pre-clinical models
US$ 28.41
US$ 24.72
US$ 25.30
US$ 25.85
